February 16th, 2012 by Katie Whittle
Official Press Release
Funding Will Help Support FitFactor Initiatives
Washington, D.C. – The Hemophilia Federation of America (HFA) today announced that the United Way of The National Capital Area has issued a $7,250 grant to help support their FitFactor program in collaboration with one of their local member affiliate chapters, the Hemophilia Foundation of Maryland (HFM). HFA was one of 700 organizations that applied for this competitive grant.
The United Way grant will ...
(Keep Reading)
February 16th, 2012 by Katie Whittle
Pfizer Hemophilia is pleased to announce that the 3000 IU dose of BeneFIX® is now available for hemophilia B patients. BeneFIX is a recombinant coagulation factor IX product indicated for the control, prevention and perioperative management of bleeding episodes in ...
(Keep Reading)
February 14th, 2012 by Katie Whittle
Link to Article
The study found that the mice which received Factor VIIa-CTP showed a superior survival rate.
Prolor Biotech Inc. (AMEX: PBTH; TASE: PBTH) today reported positive results in a comparative study of its longer-acting version of the hemophilia drug Factor ...
(Keep Reading)
February 14th, 2012 by Katie Whittle
Link to Website
IPPC 2012 SPEAKERS TO ADDRESS DEVELOPMENTS IN CLINICAL USE OF PLASMA PROTEIN THERAPIES
BRUSSELS, BELGIUM (February 14th, 2012) The International Plasma Protein Congress (IPPC) 2012 will take place on March 13-14 in Madrid, Spain at the Hotel Melia Princesa ...
(Keep Reading)
February 9th, 2012 by Katie Whittle
Link to Official FDA Alert
Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication - Drug Interactions
AUDIENCE: Infectious Disease, Pharmacy
ISSUE: FDA notified healthcare professionals and patients that drug interactions between the hepatitis C virus ...
(Keep Reading)
February 9th, 2012 by Katie Whittle
Link to PDF of New Staff Press Release
HFA Office Welcomes New Additions to Staff
Washington, D.C. – The Hemophilia Federation of America (HFA), is pleased to announce four new additions to their staff: Jane Cavanaugh Smith, Matthew Landseadel, Pat Brown, and ...
(Keep Reading)
February 7th, 2012 by Katie Whittle
Click here for FDA recall
North American Rescue, LLC Announces A Follow-Up to the Recall of Crickit® Convenience Kits Because of Possible Health Risk Related to Nationwide Recall of Triad Povidone Iodine Prep Pads
Contact:
Consumer
1-888-689-6277, Monday through Friday, 8:00am to 5:00pm (ET)
FOR ...
(Keep Reading)
January 11th, 2012 by Katie Whittle
Click for link to WFH
Montreal, Canada, January 10, 2012 — The World Federation of Hemophilia is pleased to announce the appointment of John Bournas as CEO/Executive Director. Mr Bournas brings over fifteen years of senior managerial experience in the healthcare ...
(Keep Reading)
January 6th, 2012 by Eboni Morris
On Monday, Dec. 16, the U.S. Department of Health and Human Services (HHS) released a bulletin outlining guidance to states on implementing Essential Health Benefits (EHBs). As you may recall, the Affordable Care Act will require individuals to have insurance ...
(Keep Reading)
January 5th, 2012 by Katie Whittle
Link to Baxter's Press Release
BAXTER INITIATES PHASE I CLINICAL TRIAL OF LONGER-ACTING RECOMBINANT FVIII TREATMENT FOR HEMOPHILIA A
Investigational BAX 855 is based on ADVATE Factor VIII Molecule
DEERFIELD, Ill., January 5, 2012 – Baxter International Inc. today announced the dosing of ...
(Keep Reading)
December 19th, 2011 by Katie Whittle
Direct link to Press Release
ADVATE for routine prophylaxis reduced annual bleed events in hemophilia A patients from forty-four to one as compared to an on-demand regimen in a clinical study
Once every third day pharmacokinetic dosing option offers some patients
the opportunity ...
(Keep Reading)
December 12th, 2011 by Katie Whittle
By NICHOLAS WADE
Published: December 10, 2011
Medical researchers in Britain have successfully treated six patients suffering from the blood-clotting disease known as hemophilia B by injecting them with the correct form of a defective gene, a landmark achievement in the troubled ...
(Keep Reading)
December 5th, 2011 by Katie Whittle
HFA Board Member Lew Collins has been appointed to the Texas State Bleeding Disorders Advisory Council. According to the Texas Department of State Health Services (DSHS) this advisory council will oversee: 1) public use data, outcome data, and other information ...
(Keep Reading)
